Pre-op Evaluation & Anesthetic Management: 30-Year-Old with Mitral Stenosis + Atrial Fibrillation for Laparotomy

Pathophysiologic Basis (Why This Patient is High Risk)

• LA pressure rises, transmitted back to pulmonary capillaries
• Left ventricle is chronically underloaded (reduced stroke volume)
• Right ventricle faces chronic pressure overload → RV dysfunction
• Pulmonary hypertension (initially reactive/reversible, then fixed)

• Loss of atrial kick (normally 20-30% of ventricular filling)
• Tachycardia shortens diastole - the most critical factor, as reduced diastolic filling time forces higher flow across the stenotic valve, dramatically increasing the transvalvular gradient (pressure gradient = 4v² by Bernoulli)
• Left atrial dilation + blood stasis → thrombus formation (especially left atrial appendage) → systemic embolism (most often cerebral)

• Miller's Anesthesia 10e, p. 7620; Morgan & Mikhail's Clinical Anesthesiology 7e, p. 759-761

Pre-operative Evaluation

1. History & Functional Assessment

• Symptoms: dyspnea (classify NYHA), orthopnea, PND, hemoptysis, palpitations, syncope, prior embolic events
• Duration and stability of AF - paroxysmal vs. permanent
• Current medications: rate control agents (beta-blockers, digoxin, diltiazem), anticoagulation (warfarin/NOAC), diuretics
• Rheumatic fever history (most common cause in a 30-year-old)
• History of pulmonary edema or decompensation
• Functional capacity: can the patient climb 1-2 flights of stairs (≥ 4 METs)?

2. Echocardiography (Transthoracic Echo - TTE) - Essential

• MVA (planimetry, pressure half-time) - defines severity
• Mean mitral gradient (normal < 5 mmHg; severe > 10 mmHg)
• Pulmonary artery systolic pressure (PASP)
• LV and RV size/function
• Left atrial size (enlarged LA → higher embolic risk)
• Presence of LA thrombus (if TTE inadequate, TEE needed)
• Wilkins score (for suitability of balloon valvuloplasty)

• Fuster and Hurst's The Heart 15e, p. 2098

3. Electrocardiogram

• Confirm AF (rate at rest, ventricular response)
• P-wave morphology if sinus rhythm: notched "P mitrale"
• Signs of RVH (right axis deviation, R>S in V1)
• Evidence of ischemia

4. Chest X-Ray

• LA enlargement (double opacity at right heart border, splaying of carina)
• Pulmonary venous congestion/Kerley B lines
• Pulmonary artery prominence (pulmonary hypertension)
• Mitral valve calcification

5. Laboratory Tests

• Full blood count (anemia worsens symptoms by increasing cardiac output demand)
• Renal function, electrolytes (especially if on diuretics - hypokalemia worsens AF)
• Liver function (if chronic right heart failure/hepatic congestion)
• Coagulation profile: INR if on warfarin (critical - warfarin must be managed peri-operatively)
• Blood group & crossmatch (laparotomy with potential blood loss)
• BNP/NT-proBNP if available (reflects degree of cardiac stress)

6. Anticoagulation Management

• If on warfarin: withhold 5 days pre-op, bridge with low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) until 24 hours before surgery
• NOACs are generally NOT used in valvular AF (mitral stenosis) - warfarin is preferred
• Resume anticoagulation as soon as hemostasis is secured post-operatively (typically 12-24 hours)
• Check INR on day of surgery: must be < 1.5 for safe neuraxial anesthesia, < 1.2-1.4 for major surgery

7. Rate Control Optimization

• Target resting HR 60-80 bpm pre-operatively
• Continue beta-blockers on the morning of surgery with a small sip of water (abrupt discontinuation → rebound tachycardia)
• Continue digoxin if on it (check serum levels)
• Adequate rate control should be documented before proceeding

8. Optimization of Volume Status

• Mild diuresis if evidence of congestion, but avoid dehydration
• Correct electrolyte abnormalities

9. Anaesthetic Risk Stratification (RCRI)

• High-risk surgery (intraabdominal) = 1 point minimum on RCRI
• History of congestive heart failure (if present) = additional point
• This places the patient in moderate-to-high cardiac risk category

Anesthetic Management

1. Premedication

• Continue beta-blockers and digoxin on the morning of surgery
• Anxiolysis with caution: benzodiazepines (low dose midazolam) are acceptable but avoid respiratory depression
• Avoid anticholinergics (atropine, glycopyrrolate) - risk of precipitating tachycardia
• Anti-emetics: ondansetron preferred (avoid metoclopramide - can increase GI motility and gastric pressure, less relevant; but note it has no cardiac concerns)

2. Monitoring

• 5-lead ECG - continuous rate monitoring, detect arrhythmias, ischemia
• Arterial line (radial artery) - beat-to-beat BP monitoring; allows early detection of hemodynamic deterioration; facilitates frequent blood gas sampling
• Central venous catheter - CVP monitoring, vasoactive drug infusion
• Urinary catheter - hourly urine output
• Pulse oximetry + capnography - standard
• Temperature monitoring - hypothermia increases PVR
• Intraoperative TEE - if available and feasible, provides real-time assessment of volume status, RV/LV function, and can detect dynamic changes

3. Induction of General Anesthesia

• Adequate IV access (at least 2 large-bore IVs)
• Have phenylephrine infusion/syringe ready
• Have esmolol drawn up for rate control

• Opioids: Fentanyl (3-5 mcg/kg) or morphine as part of induction attenuates the sympathetic response to laryngoscopy (prevents tachycardia); avoid meperidine (pethidine) - it has vagolytic properties and causes tachycardia
• Neuromuscular blockade: Succinylcholine is acceptable if rapid sequence needed; rocuronium (1.2 mg/kg) with sugammadex availability is preferred for RSI if full stomach

• Pre-oxygenate well (MS patients have reduced pulmonary reserve)
• Laryngoscopy stimulus should be attenuated with adequate fentanyl
• If difficult airway anticipated, awake fibreoptic intubation preferred (avoid suxamethonium-associated fasciculations and transient pressure spikes)

4. Maintenance of Anesthesia

• Volatile agents: Isoflurane, sevoflurane, or desflurane all acceptable; they cause dose-dependent vasodilation and myocardial depression - use at low to moderate MAC; sevoflurane is preferred for relatively stable hemodynamics
• Nitrous oxide: Avoid - increases PVR, worsens pulmonary hypertension; also risk of air embolism during laparotomy
• TIVA (Total IV Anesthesia): Propofol infusion + remifentanil or fentanyl provides good control; remifentanil blunts sympathetic responses well but has short duration - be prepared for post-op pain

• Avoid hypoxia (PaO2 > 80 mmHg) - hypoxia increases PVR
• Avoid hypercarbia (PaCO2 35-40 mmHg) - hypercarbia increases PVR
• Avoid excessive PEEP (reduces venous return, impairs LV preload)
• Normothermia maintained throughout (hypothermia increases PVR and promotes arrhythmias)

• Balanced crystalloids (Ringer's lactate or PlasmaLyte) in judicious volumes
• Avoid aggressive fluid loading - the narrow window between adequate preload and pulmonary edema is a hallmark of MS
• Use cardiac output monitors (pulse contour analysis, TEE) to guide fluid responsiveness
• Blood transfusion if Hb falls below 8 g/dL (anemia increases cardiac output demand)

• Phenylephrine (alpha agonist) is the vasopressor of choice: raises SVR without increasing HR
• Avoid ephedrine (beta agonist activity raises HR)
• Norepinephrine or vasopressin as alternatives if phenylephrine insufficient

• Deepen anesthesia with opioids (fentanyl bolus)
• Esmolol (IV bolus 0.5 mg/kg, then infusion) for rate control
• Metoprolol (1-2 mg IV boluses)
• If sudden SVT with hemodynamic compromise → synchronised DC cardioversion

5. Regional vs. General Anesthesia

• Neuraxial anesthesia (epidural/spinal) causes sympathectomy with sudden vasodilation - potentially dangerous in MS
• If epidural analgesia is added for post-op pain: must be titrated slowly and carefully (epidural preferable over spinal due to more gradual onset)
• Absolute contraindication to neuraxial if anticoagulated and bridging not completed

6. Anticoagulation During Surgery

• If LA thrombus identified pre-operatively, must be anticoagulated perioperatively with UFH infusion (bridging)
• Intraoperative anticoagulation management coordinated with surgical team
• Avoid heparin reversal with protamine (causes acute pulmonary hypertension)

7. Post-operative Management

• ICU/HDU monitoring post-operatively (at minimum high-dependency monitoring for 24-48 hours)
• Continue rate control: resume oral beta-blockers, digoxin as soon as tolerating oral medications
• Pain management: multimodal analgesia (paracetamol + NSAIDs if renal function permits + opioids with caution); an epidural catheter placed pre-operatively for laparotomy provides excellent post-op analgesia while reducing opioid requirement and sympathetic tone
• Anticoagulation resumption: restart LMWH 24 hours after surgery if hemostasis secured; transition back to warfarin when tolerating oral medications
• Monitor for AF with rapid ventricular response; have IV amiodarone or digoxin available
• Aggressive management of pain, shivering, and emergence hypertension (all provoke tachycardia)
• Supplemental oxygen post-op until fully recovered
• DVT prophylaxis (patient already at high VTE risk)

Summary of Key Hemodynamic Principles

• Miller's Anesthesia, 10e - Anesthetic Management of Mitral Stenosis, pp. 7620-7621
• Morgan & Mikhail's Clinical Anesthesiology, 7e - Anesthetic Management, pp. 759-761
• Fuster and Hurst's The Heart, 15e - Valvular Heart Disease, p. 2098
• Barash's Clinical Anesthesia, 9e - Preoperative Cardiac Testing
• Schwartz's Principles of Surgery, 11e - Preoperative Cardiac Evaluation

• Pathophysiology of MS + AF with haemodynamic goals table
• Pre-operative evaluation - echo findings, investigations, anticoagulation bridging, rate control optimisation, RCRI risk
• Anaesthetic management - premedication, monitoring, induction agents table, maintenance, ventilation, fluid management
• Vasopressors & rate control drug table (phenylephrine, esmolol, etc.)
• Post-operative management - ICU monitoring, analgesia, anticoagulation resumption
• "What to Avoid" summary table with rationale
• Full textbook references

1. Abbreviations with numbers (PaO2, SpO2, FiO2, CO2, etc.) - will always use the plain digit inline (e.g., PaO2) and never a Unicode subscript or anything that renders as a black square.
2. Tables - rows will always expand in height to fit their content. Long text wraps within the cell rather than overflowing outside the table border. No more truncation.